Influence of microbial infections on the progression of HIV disease
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionContrasting roles for TLR ligands in HIV-1 pathogenesis.Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infectionProgrammed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversityPhase variation among major surface antigens of Mycoplasma penetrans.Oral infectious diseases: a potential risk factor for HIV virus recrudescence?HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.Interaction between endogenous bacterial flora and latent HIV infection.HIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression.Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF.The effects of HIV infection on oral mucosal immunity.Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathwayGp120 binding with DC-SIGN induces reactivation of HIV-1 provirus via the NF-κB signaling pathwayB lymphocyte activation by coinfection prevents immune control of friend virus infection.Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.Mucosal co-infections and HIV-1 transmission and pathogenesis.Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-alpha to reactivate HIV-1 from latency.Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony.Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro.Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor-Activator Target Sequence of 5'-LTR.
P2860
Q24550678-1C0FE81D-20AA-4B52-AB63-0286284DEA16Q33700312-9D3230A4-7BF5-400A-AB51-F8FA213CA402Q33808640-103E1269-5081-4D05-96BF-571146751A77Q33834263-392B1CF6-B310-440D-9F49-DBACBAD5F5FFQ34000776-CC2B6659-B5EF-40B1-AFA3-39DE41C05ACEQ34009798-C41CE4D5-998B-45B0-9A8E-03F6FEB508A9Q34038531-7EF3944B-74C4-4F3C-9C71-B727053C1C02Q34150444-33FEAB2B-994B-4905-9E38-7E56A79C89EAQ34686713-133CE45C-EB69-44B7-AFBE-D19C2F47F29FQ35079104-39F13E5E-510B-4E4C-9F69-56237BB94164Q35088021-0C217498-4244-4F93-B4B2-34E74E9D92EAQ35556260-29259464-2046-44A1-A2C2-CD5878E52E9BQ35677628-AD8C85D4-23B9-400B-8AFD-10E7E8F80CC6Q36467653-6A8ACC01-3C9B-4EEC-AB45-02B38EB576E9Q36660185-E5B9CDEA-D600-47F6-8494-3285606ADD92Q36947125-F2481831-7FD1-4155-85F3-C6E151358329Q37128255-95F47A03-6C0F-46DC-A0E0-A4B5AD2D2D96Q37379784-3BB353BC-931B-4497-9755-F9776DAA4AECQ37555926-9B0DE74E-34A1-421D-955D-C3600C577654Q40099835-1ADBDFFA-E90F-44E1-9506-9017C096BD77Q40213577-8468375F-4C73-46A8-BC90-3BD0BFBA2832Q40525418-2095572E-70F6-44D0-BF68-C976B7301F60Q42428565-7FB56975-F605-4D9A-9C82-86FB2CA69490Q42565116-5CA984A0-7DCF-4C9F-AB38-9F15A7BB04ADQ43920738-11B5A2EC-F6B7-4F30-95FF-01DE57BD525AQ46264440-F4AE7F4C-95FB-4220-8ED9-0B78DBF52FCFQ47550764-214C8613-D64F-4054-BD02-491BEFC8A365
P2860
Influence of microbial infections on the progression of HIV disease
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Influence of microbial infections on the progression of HIV disease
@ast
Influence of microbial infections on the progression of HIV disease
@en
Influence of microbial infections on the progression of HIV disease
@nl
type
label
Influence of microbial infections on the progression of HIV disease
@ast
Influence of microbial infections on the progression of HIV disease
@en
Influence of microbial infections on the progression of HIV disease
@nl
prefLabel
Influence of microbial infections on the progression of HIV disease
@ast
Influence of microbial infections on the progression of HIV disease
@en
Influence of microbial infections on the progression of HIV disease
@nl
P1476
Influence of microbial infections on the progression of HIV disease
@en
P2093
A Blanchard
M L Gougeon
P304
P356
10.1016/S0966-842X(97)01089-5
P407
P577
1997-08-01T00:00:00Z